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In the year 2005, most of the estimated 150 million people worldwide afflicted by diabetes mellitus lived in developing countries. 1 Diabetic foot ulcers will complicate the disease in more than 15% of these people during their lifetimes. 2, 3 In prospective cohort studies conducted among those with diabetes, history of a foot ulcer increased the risk of subsequent amputation by two-to over three-fold. 4, 5 Foot ulcers precede more than 80% of non-traumatic lower limb amputations. 6 In this chapter, we will review the definition of a 'foot ulcer' and the studies that estimate the incidence and prevalence of foot ulcers, making note of issues that need to be considered in their computation. We will also review risk factors for foot ulcers from wellconducted epidemiological studies, foot ulcer outcomes and the economic impact of foot ulcers.
FOOT ULCER DEFINITION AND CLASSIFICATION
In order to estimate accurately the occurrence of diabetic foot ulcers and risk factors associated with this diabetic complication, a common definition is needed. The International Consensus on the Diabetic Foot currently defines a diabetic foot ulcer as a full-thickness wound below the ankle in a patient with diabetes, irrespective of duration. 7 The International Working Group on the Diabetic Foot (IWGDF) also recommends that studies describing the occurrence of diabetic foot ulcers use a standard classification system to facilitate communication between health care providers, provide information about the healing potential of an ulcer and help guide management decisions. Use of such a system allows a patient to be followed up over time, allowing repeated classification of the foot ulcer. Classification systems should be sufficiently robust that intra-and inter-observer variability is low (i.e. the classification is reproducible) and should be applicable worldwide. This allows research results from one study to be compared to those of others, which is important in interpretability of results. 8 For foot ulcers, one challenge in this regard has been the numerous classification systems in existence. The most commonly used system internationally is Wagner's. 9 This system specifies ulcer depth and the presence of osteomyelitis or gangrene as a five-grade continuum:
INCIDENCE AND PREVALENCE STUDIES
Reports of the incidence (new onset) and prevalence (history) of diabetic foot ulcers from many countries have begun to appear in the medical literature. To identify these studies, we conducted a literature review using the Ovid Information service, which includes Medline, the Cumulative Index to Nursing and Allied Health Literature, the Cochrane Controlled Trials register and Current Contents. We searched for articles published between January 1964 and April 2005 that used the following phrases: diabetes or diabetic, incidence, prevalence, foot ulcer, foot and feet. We also searched the bibliography of each identified article. The published studies we reviewed include population-based cohort studies, large randomised controlled trials (from which we report foot ulcer incidence among the comparison group) as well as clinic-based studies. We excluded studies that reported only lower limb ulceration (without specifying foot ulcers), 14, 15 those that did not specify a foot ulcer definition of any sort 13, 16, 17 and studies that described a series of foot ulcer patients without clearly specifying a population base that would make it possible to estimate prevalence or incidence. [18] [19] [20] [21] The lifetime risk for foot ulcers in people with diabetes has been estimated to be 15%.
2 Table 1 .1 shows that the annual, population-based incidence of foot ulcers among people with diabetes ranges from less than 1% to 3.6% among people with type 1 or type 2 diabetes. 16, [22] [23] [24] [25] [26] [27] [28] [29] [30] Several methodological issues deserve consideration by those reviewing data or estimating foot ulcer incidence and prevalence in a population:
1. A number of clinic-based studies have attempted to estimate the population prevalence (and in some cases the incidence) of diabetic foot ulcers for a geographic area. 17, 30, [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] Many of these studies were well conducted and required substantial coordination across health care systems. For example, in France, a cross-sectional survey was conducted on one day in May 2001 of all patients attending outpatient clinics or admitted by 16 hospital departments that were actively involved in managing such patients. 42 Clinic-based studies make use of accessible patients. When used to measure prevalence or incidence of foot ulcers for a geographical area in community-dwelling people with diabetes, however, this information may be biased because not all those with diabetes attend clinics, and those who do attend are more likely to have complications when they attend, such as diabetic foot problems. Moreover, cross-sectional surveys of clinic attendees that select a random or consecutive sample of clinic attendees are more likely to sample patients with more severe disease, because these patients attend the clinic more frequently. The preferable strategy is to sample patients from a diabetes registry that enrolls all patients in a region or a large health system.
2. Foot ulcer prevalence will also be underestimated if care is not taken to sample only patients with previously diagnosed diabetes, because a substantial proportion of patients are diagnosed with diabetes only at the time they present to clinics with a foot ulcer. In the Congolese survey cited, Monabeka and colleagues found that diabetes was first diagnosed in 2.8% of patients admitted for diabetic foot problems, 36 while in the United Kingdom, 15% of patients admitted for amputation were first diagnosed with diabetes on admission to hospital. 45 Investigators should be sure to include the foot ulcer cases for which diabetes is diagnosed at the time of foot ulcer detection in the population denominator, when calculating incidence or prevalence.
3. Wherever possible, reported foot ulcers (either by patients in surveys or by providers in clinics) should be corroborated by direct examination by investigators to avoid possible misclassification. Routine administrative or clinical billing data are subject to reporting bias, because health professionals may fail to enter the correct diagnostic code, or assign codes to maximise reimbursement. Reimbursement and administrative systems are not well suited to tracking clinical information such as ulcer episodes. Foot ulcer occurrence will be underestimated if more severe presentations (such as cellulitis or gangrene) are not counted as foot ulcers when disease in such patients started as foot ulcers. In one survey of 1654 diabetes patients hospitalised with foot problems in the Congo, only 1.2% of the cases were classified as foot ulcers, while 70.4% had either local abscess or wet gangrene. 36 4. Prospective studies that seek to estimate ulcer incidence in a population should define a cohort of individuals who are known to be free of foot ulcers at the onset of the study, and evaluate those individuals at a later time to determine the subsequent foot ulcer presence or absence, using a clear foot ulcer definition.
5. While randomised controlled trial cohorts allow for careful ascertainment of foot ulcer incidence, they may be unsuitable to estimate incidence in the overall population of people with diabetes in the region where the study was conducted (even in controls, or in a study where the intervention was not successful and the investigators attempt to draw conclusions from the total cohort) because the sample is often highly selected, i.e. very unlike the population from which the sampled participants are drawn. In one recent clinical trial sample that was used to estimate incidence of foot ulcers, participants must have been 18-70 years old, men or non-pregnant women, had a vibration perception threshold (VPT) of ≥25 V on at least one foot and have had no prior foot ulceration or lower limb amputation, only diabetic causes of neuropathy, and no history of alcohol abuse, previous treatment with radiotherapy or cytotoxic agents, uncontrolled hypertension or any renal disease. 25 While these criteria are suitable to enrolls participants into a controlled trial, they make it impossible to generalise results from such a study to estimate foot ulcer incidence in the general population of people with diabetes. (Reiber et al.) ; study patients were enrolled with a lesion through the dermis that could extend to deeper tissue.
ANATOMIC LOCATION OF FOOT ULCERS
The anatomic site of foot ulcers varies according to the population from which the patients are drawn. Table 1 .2 presents data from two prospective studies that reported foot ulcer site. Those studies using patients from general diabetes clinics found that the most common ulcer sites were the toes (dorsal and plantar surface), followed by the metatarsal heads.
46,47
US COUNTRYWIDE ESTIMATES OF FOOT-ULCER-RELATED CONDITIONS
The ability to identify foot ulcers in individuals in clinics, offices and outpatient settings is difficult, due to limited surveillance systems. However, information on patients hospitalised with foot-ulcer-related conditions is available in many countries. In the United States, for example, the Healthcare Cost and Utilization Project Nationwide Inpatient Sample (NIS) reports a 20% stratified sample of US community hospitals discharges (excluding discharges from Department of Veterans Affairs and military hospitals). In Table 1.3 the data for 2001 and  2002 by International Classification of Diseases (ICD-9) codes, weighted to reflect the US civilian population, show that the leading reasons for hospitalisation among diabetic patients with foot-ulcer-related conditions are cellulitis and abscess, lower limb ulcers and osteomyelitis.
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RISK FACTORS FOR DIABETIC FOOT ULCERS
Independent risk factors for diabetic foot ulcers were identified from analytic and experimental studies that used multivariable modelling techniques and included a defined foot ulcer outcome. Results shown in Table 1 .4 demonstrate that the most consistent independent foot ulcer risk factors were long diabetes duration, measures of peripheral neuropathy and peripheral vascular disease, prior foot ulcer and prior amputation. Long duration of diabetes, even after controlling for age, was a statistically significant finding in three studies. 16, 23, 24 The independent role of plantar foot pressure remains unclear. 48 Assessment of diabetic peripheral neuropathy is performed using several semi-quantitative and quantitative measures and neurological summary scores. Associations between peripheral neuropathy and foot ulcers are uniform across the studies reported in Table 1 .4. Boyko and colleagues found an increased risk of ulcers in patients who were insensate to the 5.07 (10-g) monofilament, a semi-quantitative measure of light touch. 30 , 50 Kastenbauer and associates found that elevated VPT ≥ 25 V prospectively predicted foot ulcers in a cohort of type 2 patients followed up on average for more than 3 years. 37 In a randomised clinical trial that used VPT ≥ 25 V as an entry criteria, Abbott and colleagues found that VPT deficits and a combined neuropathy deficit score (NDS) that include both reflexes and muscle strength measures were significant predictors of incident ulcers. 25 Several years later, the same investigators, in a cohort study of 6613 diabetes patients from six UK health care districts, found similarly that NDS score, increasingly abnormal ankle reflexes and 10-g monofilament insensitivity all independently predicted new foot ulcers. 27 Carrington and associates found that peroneal motor nerve conduction velocity was strongly associated with foot ulcer risk even after controlling for sensory neuropathy. 39 Together these studies suggest that aberrations in the various sensory modalities and the presence of motor neuropathy independently predict increased foot ulcer risk.
Peripheral vascular function can be measured as absent pulses, transcutaneous oxygen tension (TcpO 2 ) decrements and low ankle-arm index (AAI). These variables predicted foot ulcers in several of the studies in Table 1 .4. Low TcpO 2 , indicating diminished skin oxygenation, and low AAI, indicating abnormal large vessel perfusion, were independent predictors of foot ulcers in the study by Boyko et al. 30 In Boyko and colleagues' study, laser Doppler flowmetry did not predict foot ulcer. Kumar et al. defined peripheral vascular involvement as the absence of two or more foot pulses or a history of previous peripheral revascularisation. 24 They reported that this variable was a significant predictor of foot ulcers. Walters et al. found that an absent dorsalis pedis pulse was associated with a 6.3-fold increased risk of foot ulcer (95% CI 5.57-7.0). 23 Abbott and colleagues found that having two or less palpable pedal pulses on both feet (at the dorsalis pedis or posterior tibial arteries) predicted increased foot ulcer risk, after controlling for neuropathy measures, history of prior foot ulcer and foot deformity. 27 The proportion of foot ulcers with both neuropathy and ischaemia is fairly consistent internationally. In the United Kingdom, Kumar et al. found neuropathy alone in 46% of those with a history of foot ulcer, ischaemia alone in 12%, neuropathy and ischaemia (neuroischaemia) in 30% and neither in 12%. 24 Similarly, Walters et al., also working in the United Kingdom, and Nyamu et al. in a carefully conducted clinic-based study in Kenya found that the greatest proportion of foot ulcers were neuropathic, followed by neuroischaemic and lastly by ischaemic ulcers, and that ischaemia was present in about half the ulcers overall. 23, 40 On the other hand, the proportion of foot ulcers that are ischaemic is less in some lesser developed countries, compared to more developed countries. Morbach et al., in a study comparing foot ulcers classified by the Wagner system across several countries, found that peripheral vascular disease was present in 48% of foot ulcers in Germany, but in only 11% of ulcers in Tanzania and 10% in India. 51 The risk associated with a prior history of ulcers was assessed in five studies. Boyko 24 Rith-Najarian and colleagues (though they did not use a multivariate approach and hence their study is not shown in Table 1 .4) found an incidence rate of foot ulcers of 6/1000 person-years at risk among people with diabetes who had no history of prior foot ulcer, intact foot sensation and no foot deformity, whereas the rate was 330/1000 person-years at risk if all three of these criteria were present. 22 Health care access and availability of diabetes education have been reported to influence development of foot ulcers. In a randomised trial conducted by Litzelman et al. in a county hospital population, diabetes patients were randomised to education, behavioural contracts and reminders, while concurrently their providers received special education and chart prompts. The control population in this study received usual care and education. After 1 year, patients in the intervention group reported more appropriate foot self-care behaviours, including inspection of feet and shoes, washing of feet and drying between toes. Not all desirable behaviours were adopted. There was no significant difference between patient groups in testing of bath water temperature and reporting of foot problems. Patients in the intervention group developed fewer serious foot lesions including ulcers than did those in the control group. 49 Among the five studies reported in Table 1 .4 that included glycosylated haemoglobin (HbA 1c , indicating medium-term glycaemic control) in their analyses, 16, 30, 37, 39, 49 only HbA 1c or blood glucose levels was positively associated and foot ulcers: Moss et al. found a statistically significant association between increasingly poor HbA 1c and subsequent foot ulcers in their cohort study, with an odds ratio of 1.6 (95% CI l.3-2.0) for every 2% deterioration in this measure. 16 The relationship between smoking and foot ulcers was assessed in six studies reported in Table 1.4; 23,24,27,30,37,39 however, it was only of borderline significance in the younger population in the Wisconsin study. 16 Moss and colleagues found that current smokers younger than 30 years were more likely to ulcerate, with odds ratio 2.3 (95% CI 1.0-5.6). 16 Kastenbauer and colleagues found that daily intake of alcohol also increased ulcer risk. 37 The cohort study by Boyko et al. also identified higher body weight, insulin use and history of poor vision as three additional independent predictors of foot ulcer. 30 Four of the studies reported in Table 1 .4 address the relationship between deformity and subsequent foot ulcer. 27, 30, 37, 49 The study by Boyko et al. found an independent association between Charcot deformity and foot ulcer, but other foot deformities were not independent ulcer predictors. 30 Foot deformity did not enter the final analytic model in the studies by Litzelman et al. 49 or Kastenbauer et al. 37 A number of other studies not presented in Table 1 .4 have assessed the role of elevated foot pressure in foot ulcer development, using case-control comparisons. As long ago as 1963, Bauman and Brand found elevated plantar pressures under the feet of people with neuropathic insensitivity, foot deformities and foot ulcers. 52 Mueller and colleagues found that patients with diabetes and a history of foot ulcers had significantly reduced ankle dorsiflexion and subtalar joint range of motion, compared to those without diabetes. 53 In a similar study, Zimny et al. found that those with diabetic neuropathy but no history of foot ulcers also had reduced dorsiflexion and subtalar motion, compared to nondiabetic controls. 54 Recently, Robertson et al. found, using spiral computerised tomography, that plantar tissue muscle density was decreased and that metatarso-phalangeal arthropathy (especially hammer toe deformity) was more likely to be present in those with diabetic peripheral neuropathy and a history of plantar ulcer than in normal controls (P < 0.001). 55 In another study by the same group, Mueller et al. found that peak plantar pressure during walking was significantly greater in those who had both diabetic peripheral neuropathy and hammer toes than in normal controls. 56 Van Schie et al. found a greater frequency of both foot deformities (hammer toes, claw toes, prominent metatarsal heads and high medial arch) and foot muscle weakness (in both intrinsic and extrinsic muscles) (P < 0.001, Kruskal-Wallis test for trend in both types of comparisons) in those with a history of diabetic foot ulcers than in diabetic, non-neuropathic and non-diabetic controls. 57 In reports from prospective cohort studies, progressively higher plantar pressure predicts increasing foot ulcer risk. 35, 58 Despite these associations, prospective studies have been unable to demonstrate an optimal cut-point for increasing plantar pressure, above which the probability of foot ulceration is substantially increased. 43, 59 This may be the case because other factors, such as weight-bearing activity, act together with plantar pressure to increase foot ulcer risk. Maluf and Mueller in a case-control study found that cumulative plantar tissue stress (which they defined as the combination of plantar pressure and total daily weight-bearing activity) was reduced in those with a history of diabetic neuropathic ulcers compared to either those with neuropathy alone or non-diabetic controls (P = 0.03). 60 The authors speculated that plantar tissues in those who ulcerated may have been more vulnerable to ulceration due to disuse atrophy. That study measured plantar pressure once at study onset, and measured weightbearing activity over the ensuing week. Ledoux et al. investigated the relationship between ulcer location and peak plantar pressure at one Veterans Affairs (VA) medical centre in 549 individuals with diabetes, each of whom had in-shoe plantar pressure measured using the F-scan plantar pressure measurement device. After an average of 2.5 years of follow-up, there were 42 patients who developed plantar ulcers. In an analysis that considered whether plantar pressure differed within each foot site by foot ulcer occurrence, no significant difference was seen for peak pressure. Sites at which ulcers developed had higher mean pressure than other sites, but the site of highest pressure was unrelated to the foot ulcer site. 61 Together, these studies represent a substantial shift over time in our understanding of the role of plantar pressure and foot ulceration. It is becoming clear that while foot deformities and associated plantar pressure are important risk factors for diabetic foot ulcer, other as yet unidentified factors probably play an important synergistic role with plantar pressure in the development of foot ulcers. Further prospective studies are needed to investigate the joint role of plantar pressure and weight-bearing activity using technology that measures cumulative plantar tissue stress continuously, via an in-shoe system. Such systems are being developed 62 and will greatly improve investigation in this area. Table 1 .5 shows the outcomes of incident ulcers reported from three prospective studies of foot ulcers. The proportion of patients with diabetic foot ulcer who progress to at least partial amputation ranges from 11 to 24%, depending on ulcer severity and length of followup. 26, 28, 46, 47, 63 Factors associated with amputation once foot ulcer occurs will be reviewed in the next chapter. Later chapters will review therapeutic strategies for treatment of diabetic foot ulcer; however, a number of studies have found that, given similar care, ulcer surface area and ulcer duration prior to the start of treatment delay ulcer healing. 13, [63] [64] [65] [66] In a study of 194 ulcers that were re-examined weekly for 6-18 months, Oyibo and colleagues found that ulcer surface area differed strongly and significantly between ulcers that healed, did not heal or proceeded to amputation (larger ulcers having worse outcomes and taking longer to heal). Patient gender, age and duration of diabetes at presentation, and site of the ulcer on the foot did not affect time to healing. Neuroischaemic ulcers took longer to heal (20 vs 9 weeks) and were three times more likely to lead to amputation. 63 Margolis and colleagues found, after pooling data from the control arms of five related randomised studies investigating new ulcer-healing therapies, that neuropathic wounds were more likely to heal within 20 weeks if they were smaller (<2 cm 2 ), had existed for a shorter period before they were treated (<6 months) or if the patients were of non-White ethnicity. 13 Gender, age and glycosylated haemoglobin level had no effect in their multivariable regression model. In an analysis that utilised medical records from 150 wound care facilities in 38 US states, these same investigators confirmed that among 72 525 diabetic foot wounds in 31 106 patients, wounds that were older, larger and deeper in grade (especially Wagner grade ≥ 3) were more likely to take more than 20 weeks to heal, after adjustment for gender and age. 64 Pecoraro and colleagues described the importance of a 4-week reduction in ulcer volume and reported that low levels of periwound TcpO 2 and CO 2 were significantly associated with initial rate of healing, while an average periwound TcpO 2 <20 mm Hg was associated with a 39-fold increased risk of early healing failure. 66 Sheehan and colleagues similarly found, among 276 patients with Wagner grade ≥ 1 diabetic foot ulcers of 30 days duration, that change in ulcer area within 4 weeks of treatment onset strongly predicted complete wound healing by 12 weeks. 65 All patients in each of these studies received similar ulcer care, which included offloading, wound debridement and moist wound dressings. 13, [63] [64] [65] Foot ulcer recurrences were addressed in a UK study by Mantey and colleagues. 67 Diabetic patients with an initial foot ulcer and two ulcer recurrences were compared with diabetic patients who had only one ulcer and no recurrences over a 2-year interval. The authors reported greater peripheral sensory neuropathy and poor diabetes control in the ulcer recurrence group. Members of the ulcer recurrence group had higher glycosylated haemoglobin levels, waited longer after observing a serious foot problem until seeking care and consumed more alcohol than did the group without ulcer recurrences. Several years later, Connor and Mahdi reported on their cohort analysis of 83 patients followed up for 2-10 years after their initial foot ulcer. 68 They found that the 37% of patients with a higher rate of recurrence (≥3.5 ulcers per foot per 10 years) accounted for 68% of all inpatient days and 75% of all amputations. These patients fell into two distinct groups: those with neuroarthropathy, who were more likely to wear non-orthotic footwear and had problems with footwear or orthoses, and those without neuroarthropathy, who attended clinic irregularly. Both groups had poorer glycaemic control than those with less ulcer recurrence. EPIDEMIOLOGY AND ECONOMIC IMPACT OF FOOT ULCERS (Reiber et al.) ; study patients were enrolled with a lesion through the dermis that could extend to deeper tissue.
ULCER OUTCOMES
ECONOMIC CONSIDERATIONS FOR FOOT ULCERS
Studies on foot-ulcer-related conditions usually report only direct patient costs or charges such as outpatient visits, procedures, pharmaceuticals and hospitalisations, since indirect costs (value of lost income from work, pain, suffering and family burden) are difficult to measure. Two studies assessed the economic impact of ulcers and amputations, and followed the lesion from the onset of the ulcer episode to each lesion's final resolution. Ramsey conducted a nested case-control study in a large health maintenance organisation (HMO) that involved 8905 patients with diabetes. Of this group, 514 individuals developed one or more foot ulcers, and 11% of these patients required amputation. Costs were computed for the year prior to the ulcer and the two years following the ulcer, for both cases and controls. The excess cost attributed to foot ulcers and their sequelae averaged $27 987 per patient for the 2-year period following ulcer presentation. 26 Apelqvist followed 314 patients across their ulcer episode, and reported healing was achieved in ≤2 months in 54% of patients, in 3-4 months in 19% of patients and in ≥5 months in 27% of patients. There were 63% of patients who healed without surgery at an average cost of $6664. Lower limb amputation was required for 24% of patients at an average cost of $44 790. The 13% of patients who died prior to final ulcer resolution were excluded from this analysis. The proportion of all costs that were related to hospitalisation was 39% among ulcer patients and 82% among amputees. 69 Direct costs for US patients with private insurance are available from the Medstat group, who manages a large US integrated administrative claims system affiliated with private health insurance plans. Table 1 .6 shows reimbursement to hospitals for patients with selected foot conditions by Diagnostic Related Group (DRG). For example, for DRG 271, i.e. skin ulcers, patients with private insurance averaged 11-day hospitalisation at a cost of $11 638, while those whose coverage was Medicare had an average 7.3-day length of stay and an average hospital reimbursement of $5227 according to the Centers for Medicare and Medicaid Services. Payment for the health care providers is not included in these figures. 70, 71 In summary, foot ulcer prevalence and incidence is increasing globally and is challenging to measure, due to a lack of outpatient-and clinic-based surveillance systems. Peripheral neuropathy and its sequelae, a long duration of diabetes and peripheral vascular disease are the most consistent risk factors for predicting a foot ulcer. Re-ulceration occurs in about 60% of persons with prior ulcers and is more common among those with more severe peripheral neuropathy, increased alcohol consumption, poorer blood glucose control and delays in seeking ulcer care. Costs are high to the patient and the health care system.
